Australian industry calls on government to save the PBS

6 February 2014
canberra-big

Medicines Australia has called on the Australian government to save the Pharmaceutical Benefits Scheme (PBS) by delivering stable policies that support the medicines industry and ultimately Australian patients.

“Medicine Australia’s Budget submission sets out six measures that will protect the PBS for future generations,” said Brendan Shaw, the trade group’s chief executive. “It also outlines what measures are needed to maintain a viable and thriving medicines industry, which last year generated over A$4 billion ($3.5 million) in exports, and invested over A$1 billion in research and development for the fourth consecutive year,” he added.

The submission details the significant savings to the Australian government achieved through successive rounds of reforms in 2007, 2010 and 2013.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical